Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (351-360 of 606) with videos related to

Pageof 61
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Impact of genome build on RNA-seq interpretation and diagnosticsRachel A Ungar, Pagé C Goddard, Tanner D Jensen, et al.
The Journal of Pediatrics|December 9, 2008
Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolismIsabelle R Miousse, David Watkins, David Coelho, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 16, 2025
Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacksH Henry Li, Emel Aygören-Pürsün, Markus Magerl, et al.
Pediatric Neurology|April 13, 2016
Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement DisorderAmitha L Ananth, Amy Robichaux-Viehoever, Young-Min Kim, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 13, 2013
Chronic traffic pollution exposure is associated with eosinophilic, but not neutrophilic inflammation in older adult asthmaticsTolly G Epstein, Banurekha Kesavalu, Cheryl K Bernstein, et al.
Biological Psychiatry|September 13, 2020
Network Effects of the 15q13.3 Microdeletion on the Transcriptome and Epigenome in Human-Induced NeuronsSiming Zhang, Xianglong Zhang, Carolin Purmann, et al.
Plos Genetics|July 1, 2021
Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicityAaron D Besterman, Thorsten Althoff, Peter Elfferich, et al.
Pageof 61

Showing results (351-360 of 606) with videos related to

Sort By:
Pageof 61
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Impact of genome build on RNA-seq interpretation and diagnosticsRachel A Ungar, Pagé C Goddard, Tanner D Jensen, et al.
The Journal of Pediatrics|December 9, 2008
Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolismIsabelle R Miousse, David Watkins, David Coelho, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 16, 2025
Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacksH Henry Li, Emel Aygören-Pürsün, Markus Magerl, et al.
Pediatric Neurology|April 13, 2016
Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement DisorderAmitha L Ananth, Amy Robichaux-Viehoever, Young-Min Kim, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Clinical and Translational Allergy|October 19, 2017
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extensionMarc A Riedl, Jonathan A Bernstein, Timothy Craig, et al.
Allergy and Asthma Proceedings|March 15, 2013
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation studyWilliam R Lumry, Jonathan A Bernstein, H Henry Li, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 13, 2013
Chronic traffic pollution exposure is associated with eosinophilic, but not neutrophilic inflammation in older adult asthmaticsTolly G Epstein, Banurekha Kesavalu, Cheryl K Bernstein, et al.
Biological Psychiatry|September 13, 2020
Network Effects of the 15q13.3 Microdeletion on the Transcriptome and Epigenome in Human-Induced NeuronsSiming Zhang, Xianglong Zhang, Carolin Purmann, et al.
Plos Genetics|July 1, 2021
Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicityAaron D Besterman, Thorsten Althoff, Peter Elfferich, et al.
Pageof 61